Unmasking Late Neurological Recovery through Reduced Intrathecal Baclofen

Abstract

Abstract This case report explores the intricacies of utilising intrathecal baclofen (ITB) therapy for spasticity management and its impact on neurological recovery. Baclofen, a GABAB agonist with antispasmodic properties, has gained prominence in treating spasticity and muscle spasms related to neurological conditions. This report sheds light on a patient who was under ITB treatment and experienced unexpected late-stage improvements in motor function after the dose was inadvertently reduced. The study underscores the need for careful dosing adjustments to unveil potential neurological recovery masked by ITB therapy. The case highlights the importance of multi-physician communication and frequent dosage evaluation in long-term intrathecal therapy. Moreover, it calls attention to the possibility of motor recovery years following a traumatic brain injury, emphasising the role of neuroplasticity in such cases.